Bio-Techne signals beyond the news: 53+ signals from 5 sources
The latest Bio-Techne signal on this page is from Sep 29, 2026 (Patents): "Bio-Techne Corporation's patent output is steady: 1 grant in the past year, 0 in the past 30 days." The busiest sources: Glassdoor (15+), LinkedIn (15+) and YouTube (11).
Public (TECH)Biotechnology Research1,001 to 5,000 employeesbio-techne.comLinkedIn
- Signals
- 53+
- Sources
- 5
- Last 90 days
- 18
- Latest
- Sep 29, 2026
Other signals · latest 10
Latest Bio-Techne signals by source
53+ signals for Bio-Techne across 5 sources.
Patents · Patent pace
Bio-Techne Corporation's patent output is steady: 1 grant in the past year, 0 in the past 30 days.
Over the past year Bio-Techne Corporation received 1 US patent grant; the recent pace (1 in 90 days) is steady versus its trailing baseline.
- Grants, 12 months
- 1
- Grants, 90 days
- 1
- Grants, 30 days
- 0
- USPTO assignee
- Bio-Techne Corporation
Glassdoor · Growth opportunities
Employees report lack of growth opportunities and encouragement
One review explicitly states that employees are not encouraged to grow in their roles, contributing to a low career opportunities rating of 3.0.
- Overall rating
- 3.3 of 5
- CEO approval
- 55%
- Reviews read
- 1
- Sentiment
- Negative
Glassdoor · Consistent leadership complaints
Reviews indicate poor management and micromanagement by leadership
A reviewer describes terrible management and micromanagement, with a lack of encouragement for role growth. The overall management rating is also low at 2.7.
- Overall rating
- 3.3 of 5
- CEO approval
- 55%
- Reviews read
- 1
- Sentiment
- Negative
LinkedIn
Bio-Techne reports improved Q4 and FY26 performance, awaiting acquisition by Merck KGaA.
Our fourth quarter and fiscal year 2026 (FY26) results are out, with Bio-Techne ending FY26 with improved performance and excellent execution. These results position us well for an exciting future, including through the planned acquisition of Bio-Techne by Merck KGaA, Darmstadt, Germany. We look forward to the...
- Likes
- 113
- Comments
- 3
- Tags
- Corporate Strategy, Mergers & Acquisitions, Financial Reporting
- Initiatives
- acquisition by Merck KGaA, Darmstadt, Germany
Patents · Patent counsel
Bio-Techne Corporation uses Mueting Raasch Group as outside IP counsel.
Mueting Raasch Group is the attorney of record on Bio-Techne Corporation's recent US patent work, including a grant in 2026-08.
- Law firm
- Mueting Raasch Group
- Law firm domain
- mrgiplaw.com
- Matter date
- Aug 11, 2026
LinkedIn
Receptors North America Commercial Meeting celebrates achievements and aligns on priorities for the year.
The strength of our business comes from the expertise and passion of our people. Our North America Commercial Meeting brought colleagues together to celebrate achievements, align on priorities, and build momentum for the year ahead. With our customers at the heart of every conversation, teams from across the region...
- Likes
- 146
- Comments
- 2
- Tags
- Corporate Strategy
YouTube
Bio-Techne Corp ($TECH) Q1 2026 Earnings Call
Bio-Techne Corp ($TECH) held its Q1 2026 earnings call to discuss financial performance.
- Channel
- Castify Earnings Call
- Views
- 2
- Comments
- 0
- Tags
- Earnings Call, Biotechnology, Financials
YouTube
Bio-Techne: Quiet Powerhouse in Life Sciences 🔬
Bio-Techne focuses on its research tools business and innovation-driven portfolio supporting scientific demand.
- Channel
- InsightfulValue Official
- Views
- 1
- Comments
- 0
- Tags
- Life Sciences, Research Tools, Biotechnology
Employee growth · Research team growth
29 Research employees (14.7% of company), declining significantly (-12% YoY).
The Research department currently has 29 employees out of 197 total (14.7%). The department is declining significantly (-12% YoY), representing a change of approximately -4 employees.
- Department
- Research
- Department headcount
- 29
- Department growth, 1 year
- -12%
- Total headcount
- 197
Employee growth · Engineering team growth
33 Engineering employees (16.8% of company), growing rapidly (10% YoY).
The Engineering department currently has 33 employees out of 197 total (16.8%). The department is growing rapidly (10% YoY), representing a change of approximately +3 employees.
- Department
- Engineering
- Department headcount
- 33
- Department growth, 1 year
- +10%
- Total headcount
- 197
Showing 10 of 53+ signals. The Signal API returns all of them.
Get them with one API callSignal API · MCP
Track Bio-Techne with the Signal API
One POST /v1/companies/enrich call with bio-techne.com returns Bio-Techne signals from 14 more signal types (reddit-company, podcast-company, glassdoor-company and more), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{
"domain": "bio-techne.com",
"signal_types": ["reddit-company","podcast-company","glassdoor-company",
"product-reviews","linkedin-post-company","twitter-company-posts",
"youtube-company","website-intelligence","patents-company",
"federal-contract-award","conference-speaker","hackernews",
"producthunt-launch","seo-traffic"],
"limit": 20
}'Same industry
Other signals at related companies
Questions about Bio-Techne other signals
What signals does Autobound track for Bio-Techne besides news and filings?
What are people saying about Bio-Techne online?
What do employees say about working at Bio-Techne?
Has Bio-Techne been granted patents recently?
Source. Reddit, podcasts, Glassdoor, product reviews, LinkedIn, X, YouTube, company websites, patents, federal contracts, conference talks, Hacker News, Product Hunt, web traffic and employee growth, from the Signal API.
Method. The latest 15 signals per source from the last 12 months. Posts that do not name the company, replies, repeats and unreadable rows are removed. Traffic and headcount keep their newest measure.
Data as of .